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Abstract 
Aims: To examine the effectiveness of the current diagnostic and treatment approach of 
overactive bladder (OAB) and the relative impact of cognition on what is currently a bladder-
centric condition. Methods: A review of the literature on OAB from the population to 
organ/brain level was conducted. The impact of age-induced bladder dysfunction via cognitive 
changes to sensory integration and attention control are discussed. Results: OAB uses bladder-
centric terminology to represent a collection of symptoms with inconsistent and often unknown 
pathology.  Proposed etiologies and therapeutic models for overactive bladder focus on the 
bladder organ, but evidence suggests that age-related degradation to inhibitory neural circuits 
and attentional switching mechanisms may enhance myogenic dysfunction or be implicated in 
idiopathic diagnoses. There is potential for cognitive-level interventions and research that may 
reduce the significant public health burden of OAB and related bladder dysfunctions. 
Conclusions: The influence of cognitive dysfunctions on bladder control emerges as a 
potentially substantial determinant of population OAB burden. 
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Introduction 
Our population is aging and projections estimate that by 2030 there will be more adults 
over 65 than children under 10 for the first time in world history.1 As people age, chronic 
diseases become more prevalent and often present simultaneously, with 62% of Americans over 
65 having at least two chronic conditions.2 Chronic diseases now account for over 87% of the 
disease burden in the over-60 population globally and are the most common causes of mortality.3 
The 21st century presents public health with the new challenge of accounting for the 
disproportionate ratio of life years to health years. Confronting the burden of disease in the aging 
population will prove to be an urgent consideration as the global over-60 population increases to 
two billion by 2050.4 
Overactive bladder (OAB) is a common urological disorder consisting of urinary urgency 
accompanied by urgency incontinence, frequency or nocturia in which no precise cause can be 
identified.5 OAB is highly prevalent and imposes significant burden to public health. In the U.S. 
adult population, the prevalence of experiencing OAB symptoms at least “sometimes” is 27.2% 
and 43.1% for men and women respectively.6  It is predicted that 41.9 million people in the U.S. 
will be affected by OAB in 2020, up from 34 million in 2007.7 It can impact people of any age 
and it is estimated to affect up to 50% of adults over 75.6 The number of those suffering with 
OAB will rise as the aging population is increasing on a scale unparalleled in human history.  
Bladder dysfunction is not only ubiquitous but can be exceedingly bothersome.  It is 
estimated that 65% of people with OAB report their condition having an effect on their daily 
life.8 Longitudinal studies of OAB suggest that it is a chronic condition and that symptom 
prevalence and severity tends to increase with age.9,10 Increasing severity is also associated with 
decreasing health related quality of life (HRQoL) physical and mental health scores. 9,11 Bladder 
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dysfunction may account for population-level trends in HRQoL seen in aging adults. Those who 
suffer with OAB report feeling isolated and hopeless and have higher levels of fatigue, 
depression, anxiety, and suicidal ideation.12-15 They are at risk for early retirement, 
unemployment, and comorbid conditions, threatening physical and economic public health.16-18 
The cost and impact on quality of life are comparable to that of other chronic diseases.7,19 The 
effect of moderate bladder dysfunction on quality of life is similar to having diabetes, high blood 
pressure, or cancer; and the effect of severe bladder dysfunction is similar to having a heart 
attack or stroke.20 There are also enormous societal costs associated with OAB. In 2020, annual 
per capita and total national costs of OAB are predicted to be $1,969 and $82.6 billion 
respectively, including the costs of related diagnostic tests, treatments, long-term care and 
sanitary products.7 Indirect costs, including missed work due to OAB and disability also 
significantly impact the population. Yet despite extensive research, the etiology and natural 
history of OAB remain a mystery.21  
Specific Aims 
OAB has a major impact on public health, however it presents as a diverse 
symptomology with numerous etiologies and inconsistent treatment. This paper questions the 
ability of the term OAB to sufficiently capture the complexity and heterogeneity of this condition 
at the individual or population level from the perspective of clinical diagnosis, contributing 
factors and treatment. An inadequate term does not contribute to precise diagnosis, deterring 
thorough treatment. An inadequate term also obstructs appropriate research, specifically in the 
area of cognitive control. Current OAB theories revolve around the bladder organ, yet there is 
evidence that investing research into the relationship between the brain and the bladder could 
reveal pathways for intervention and ameliorating OAB symptoms. 
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Therefore, I suggest the following hypotheses: 
Hypothesis 1: Defining OAB based on symptomology alone is an ineffective strategy for 
characterizing an idiopathic chronic condition.  
Hypothesis 2: There is a failure of linkage between symptoms and function in the current 
OAB disease model. OAB etiology changes with age and overlaps with other urinary symptom 
complexes, suggesting an underlying age-related condition uncorrelated with symptoms. 
Hypothesis 3: Overactivity of the bladder organ itself is augmented by the underactivity 
of cognitive control; suggesting OAB dysfunction does not originate solely from the bladder as 
the name implies. 
A paradigm shift from bladder-centric to cognitive-inclusive brings into question the term 
OAB, the relative impact of neural control, the influence of aging, and proposed treatments. The 
results of this hypothesis paper will encourage future research into the effect of cognitive decline 
on attentional mechanisms affecting bladder control. 
Background 
Chronic Disease Perspective 
Chronic diseases pose a novel threat to global health as lifestyles change and people live 
longer. Compared to infectious diseases, which historically represented the greatest danger to 
morbidity and mortality, chronic diseases tend to be a result of life-long lifestyle decisions, 
impacting an individual holistically on a multi-system level. Medicine has historically 
understood disease on the organ level, or smaller, assuming that organ systems function 
independently. However, the human body relies on system unison and larger networks to 
function.  Aging physiology is affected by a broadening of the network of pathology in the body, 
confounded by multiple chronic conditions and decline in function.22 Age is the greatest risk 
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factor for almost every major cause of morbidity and mortality in developed nations.23 Diseases 
related to aging are complex, highly interrelated with other pathology, and originate on the larger 
system level.24 Geriatric conditions do not adhere to the conventional organ and discipline 
boundaries of medicine, proving a challenge to diagnose and treat.25 
This interrelatedness of aging conditions suggests that there are causal commonalities 
across the spectrum of those diseases. Geroscience is a new interdisciplinary field of research 
that seeks to determine the underlying mechanisms that link aging to chronic diseases to create 
prevention strategies for multiple diseases at once.26 The name “overactive bladder” reflects the 
traditional but now antiquated medical tradition of pinpointing a specific organ as the hallmark 
of a condition. OAB is an oversimplified term assigned to a complex and multi-system problem. 
Most medicines target the bladder detrusor muscle, reducing the afferent signals it sends or 
paralyzing the muscle itself.27 However, the symptoms cannot be neatly tied together and 
treatments are only effective for a minority of patients.28,29 It is crucial to understand chronic 
conditions such as OAB on the system level, from a geroscience approach. I propose that the 
term OAB is still clouded by an outdated understanding of symptom linkage to function that 
excludes the possibility for a cognitive relationship. Thus, there is a need to examine OAB from 
an interprofessional perspective to comprehend the complexities of this chronic conditions.  
History of Terminology 
OAB is defined as a complex of symptoms with no presumed predisposing or causative 
pathological conditions or infections.5 Although multiple pathologies increase risk of OAB, the 
link between symptoms and pathology is not clear.30 Urinary urgency, incontinence, frequency 
and nocturia tend to present simultaneously.31 This pattern of co-occurring symptoms involved in 
bladder control without a reliable biomarker led to creation of the term OAB to unify them under 
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one diagnosis. The term OAB has only come into popular use within the last couple decades; 
first appearing in the literature in 1989 and reaching popularity in 1997.32,33 In 1998 the U.S. 
FDA approved medication for patient-reported OAB symptoms, when previously it could only 
be prescribed to dysfunction confirmed by urodynamics. Patients could then report their own 
symptoms and receive treatment without needing medical tests.34 In 2002 the International 
Continence Society defined OAB as “urinary urgency with or without urgency urinary 
incontinence (UUI), usually accompanied by frequency and nocturia, in the absence of urinary 
tract infection (UTI) or other obvious pathology”. Urgency is defined as “sudden, compelling 
desire to pass urine that is difficult to defer”.5 This development brought incontinence care into 
the realm of the primary care provider and helped raise public awareness of this traditionally 
neglected problem. At the same time, a number of unintended consequences also followed the 
use of this tidy OAB definition. It quickly oversimplified a complex constellation of symptoms. 
Pharmaceutical companies profited from the simplification of the problem by assigning easily 
understood medical solutions.34 In an attempt to understand and treat patients suffering from 
OAB symptoms, the creation of the term inadvertently reduced the need to understand the 
etiology of individual symptoms.  
The ICS definition uses vague terminology such as “with or without” and “usually” and 
fails to define what might constitute “other obvious pathology”.5 Throughout the years, the 
definition has been interpreted differently depending on the researcher.30 Epidemiologic research 
specific to OAB was inconsistent before the ICS definition in 2002. Slight differences in 
interpretation and use of the definition have caused broad variations in study outcome. There are 
some controversies in the understanding of the ICS definitions. Nocturia is defined as waking at 
night “one or more times to void”, preceded and followed by sleep.5 Many experts believe that 
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one void at night should not be considered nocturia, and many studies therefore also use a 
definition of at least two voids.8,18,35 Urgency is the subjective complaint of a “sudden 
compelling desire to pass urine that is difficult to defer” and many patients have trouble 
distinguishing this clinical symptom from normal urges.36 There have been proven difficulties of 
understanding OAB symptoms through questionnaires, with people misinterpreting questions 
and answering differently in subsequent interviews.37 Due to different definitions of symptoms, 
different study objectives, and different methods of measurements, research studies often get results 
that cannot be compared.38 The EPIC study used the 2002 ICS definition of nocturia as at least one 
nocturnal void per night and found high prevalence (49% men; 55% women).18 When nocturia was 
defined as two or more void per night, the prevalence rates were reduced substantially (21% men; 
24% women).18 The EpiLUTS survey used a definition with symptoms occurring “sometimes” and 
subsequently “often” and found overall OAB prevalence of 36% and 25% respectively.39 Experts 
disagree on the definition of the OAB condition, and subsequently on the evaluation of patients and 
requirements for diagnosis.40 Although there is an agreement that OAB is a chronic condition with 
inconsistent symptoms and no cure; there must also be a consensus on terms so as not to confuse 
future research and inhibit the public health response.40 The definitions of any disease and disease 
process impact all aspects of patient care. How we define a disease frames the diagnosis 
requirements, proposed management, scale of outcomes measured, and research potential. 
Methods 
 Several procedures were followed for the completion of this narrative review and hypothesis 
paper. Hypothesis formulation was generated from an extensive literature review to examine the gaps 
in the literature and direction of prospective research. The literature review was conducted using 
UConn Health Library database searches with keywords including “overactive bladder” 
 7 
“incontinence” “urgency” “prevalence” “age” “quality of life” “health care-seeking” “brain or 
neural*bladder”. Only English language papers were reviewed. The literature was analyzed using the 
software TagNotate, where each article was annotated using tags related to OAB experience and 
physiology. In total 124 tags were created to organize themes uncovered in literature (e.g. 
incontinence subtypes, lower urinary tract symptoms, study designs, etc.). The tags also labeled 
details within those topics (e.g. SUI, MUI, UUI; urgency, frequency, nocturia; longitudinal, meta-
analysis, case-control, etc.) directly in the papers to be easily pulled up with critical sections 
highlighted. This process created a personalized database with literature easily accessible to clearly 
discern overarching themes and define the shortcomings of the available information. I 
communicated with experts in the urology, aging, and cognition fields to confirm I had the most up 
to date research and receive guidance on clinical perspectives. To elucidate my hypothesis goals, I 
created stratifications of OAB experience by age and of OAB compared to UAB. Relevant themes to 
stratify by were determined by available data from my review that best represented the condition. 
Analysis of the review results was done by drawing together information about history, prevalence, 
stratification, impact, assumed pathology, and making conclusions about areas of study that have yet 
to be understood. 
Results 
Hypothesis 1: Ineffectiveness of Characterizing OAB with Bladder-Centric Symptomology  
Public health should focus attention toward improving health conditions of most at-risk 
populations. For OAB, aging adults represent a vulnerable population due to high prevalence and 
severity of co-morbid diseases and conditions among older adults with OAB and other bladder 
dysfunctions. Prevalence and severity tends to increase over time with OAB without 
incontinence tending to precede OAB with incontinence.9,10 Those with OAB report worse 
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HRQoL compared with those without OAB.9 OAB is unique in that it is not life-threatening but 
imposes an impact on mental and physical HRQoL similar to other life-threatening conditions.41  
The current disease model of OAB leaves a large portion of the aging population 
untreated and at risk of poor health. Many older adults with OAB and incontinence do not seek 
help despite symptom severity.42 Often they demonstrate a lack of understanding about 
symptoms and treatments or consider bladder symptoms to be a normal consequence of aging. 
12,43,44 This lack of understanding leads to disappointment in treatment outcome.44 Symptom 
bother also tends to be higher in patients who are uncertain about their urinary symptom etiology 
or disease course.45 Holding this confused perspective about OAB and other chronic diseases 
paints it as inevitable, and incurable in the mind of the patient, reducing their likelihood to seek 
help.37,44 Presently, only 66% of women with OAB think it is a medical condition, and far fewer 
know that there are treatments available.46,47 Treatment-seeking patients are only representative 
of a fragment of the population who suffer from OAB, but of those who are diagnosed with 
OAB, 76% continue to live with untreated symptoms.48 Although they could have benefited from 
treatment, the majority of OAB sufferers are isolated in determining their coping strategies and 
experience diminished QoL.4949 It is crucial that older adults seek help for their condition. 
Confusion about the symptom etiology is one impediment to effectively reducing disease 
burden with the current bladder-centric paradigm and can lead to harmful cultural ideas about the 
disease. Bladder dysfunction and incontinence are often perceived as a “retreat to infancy” and 
universal symptoms of social incompetence and disgust, promulgating stigma.12,50,51As a result, 
only 46% of those with OAB consult a doctor about their symptoms.52 Different cultural ideas 
about OAB stigma lead to many of the disparities seen in health seeking behaviors.53 If they do 
seek treatment, women wait on average 3.1 years before consulting a physician about OAB 
 9 
symptoms.49 Undiagnosed OAB, as a result of stigma and embarrassment, leaves many without 
an identity as a patient or an explanation for their behaviors, often resulting in even greater 
psychological costs.12  OAB patients suffer without a known etiology, often encouraging self-
blame and the idea that symptoms are a result of psychological weakness.37 Submitting to the 
condition as an “old people disease” leads to poor QoL and various detrimental coping strategies, 
including withdrawal and resignation.12 Shame related to OAB increases the number of older 
adults implementing coping mechanisms such as using sanitary protection, staying home from 
work, and avoiding family and friends to evade leakages and embarrassment.37 These strategies 
often lead to isolation and depression, and may postpone necessary health care-seeking.12,54  
A lack of clarity about OAB etiology coupled with the resulting cultural stigma makes 
treatment a complicated process for patients and their physicians. Reluctance of the patient to 
disclose their symptoms to their physician is an initial impediment to treatment. The gap between 
OAB symptomatology and healthcare-seeking behaviors poses a critical public health threat. If 
physicians then share their perspective that OAB is normal aging and not worth investigating as 
many do, even fewer OAB patients find useful treatment. Lack of information and support from 
medical professionals leads to undertreated populations.44 Although OAB is not curable, 
treatment gives people an identity as a patient that helps normalize the condition.12  
Despite the related stigma for OAB sufferers, physicians are nine times less likely to 
bring up bladder concerns than patients.55 Studies show that physicians also insufficiently 
address the impact of OAB on QoL when discussing the condition with patients.56 OAB patients 
are often dissatisfied with their care and many believe that their doctors do not take their 
experience seriously.53 Although clinical dialogue regarding OAB is physician-centered, 
research shows that patient-centered communication (PCC) is correlated with more effective 
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management of OAB.56 In 2001, the Institute of Medicine identified PCC as a key aspect of 
high‐quality healthcare and it has since become an increasingly important part of the research 
and healthcare lexicon.57 The movement towards PCC internationally will impact the way the 
medical world views OAB. Despite all the research, very few initiatives directly increase 
physician attention to lower urinary tract symptoms (LUTS).  
Without reliable healthcare seeking, population prevalence of OAB can’t be estimated 
from medical records, adding complexity to epidemiological studies. It is essential that these 
studies reveal the magnitude of the population burden, yet due to inconsistent research methods 
and study terms, the results differ broadly. Consequently, medical centers and epidemiologists 
only see “the tip of the urological iceberg,” which is what makes it such an interesting and 
complicated topic.58 Using bladder-centric terminology, therapeutic practices, and research might 
leave susceptible individuals without a course of prevention or remedial action. Living with a 
vague diagnosis of OAB and lack of a cure is associated with significant bother that increases 
with age.52  
Hypothesis 2: Failure of Linkage of Symptoms to Function 
Diagnosing techniques 
Appropriate diagnoses are crucial for reducing population burden, but without a firm 
understanding of pathology attempting accurate and precise diagnoses may be ineffective. 
Bladder dysfunction can be diagnosed by invasive tests called urodynamics studies (UDS), but as 
a symptom complex, patients can identify themselves as having OAB thus forgoing the need to 
invest the time into an invasive diagnosis. Clinical algorithms for treating OAB use patient report 
to diagnose OAB and often reserve UDS for failures in treatments.30 OAB is considered a 
problem with the detrusor muscle and UDS is a method for diagnosing detrusor overactivity 
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(DO). However, LUTS were recognized as poor predictors for urodynamic function long before 
the use of the term OAB.59 Only 54-64% of patients with OAB have urodynamic results proving 
DO 60,61 Inversely only 82% of patients with DO have symptoms suggestive of OAB.61 When 
DO is accurately identified as the source of OAB symptoms, the DO may not persist over time 
despite the persistence of symptoms.62 The incidence of persistent DO after 5 years is only 
57%.62 OAB is a chronic condition, yet often follows a pattern of incidence and remission.38 
 Despite all the clinical focus on the bladder as the source of dysfunction, it often proves 
an unreliable witness to underlying OAB conditions. This phenomenon highlights the disparity 
between symptoms and function. It explains how challenging it can be to effectively treat OAB 
based on symptoms or proven dysfunction. A bladder-centric model of treating OAB is 
insufficient for understanding the multifactorial condition. 
Therapies 
   Although available treatments for OAB patients have vastly improves over the last 50 
years, none are entirely curative as underlying disease mechanisms remain mysterious. A limited 
understanding of OAB pathogenesis and how it uniquely presents in each patient makes 
prescribing treatment challenging. Drug companies stepped into this void of uncertainty and 
assigned drugs that aim to reduce symptom burden but fail to address the cause.28 Effective 
treatment is determined through trial and error, leaving many patients dissatisfied and 
discouraged from continuing any treatment.37 Only 56% of women feel their OAB medication is 
effective.44 Most people only spend a few months taking OAB medication before giving up on 
them, and some even switch medication many times before quitting.37 
In the absence of reliable UDS testing, OAB patients are often incorrectly assigned 
anticholinergics, particularly antimuscarinics. Antimuscarinics bind to receptors on the bladder 
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muscle in order to block the input sent to contract the muscle.27 These drugs reduce the intensity 
of involuntary bladder contractions that can cause urgency and leakage. Unfortunately, 
muscarinic receptors exist all throughout the body and many antimuscarinic drugs are non-
specific, affecting other processes and causing bothersome side effects such as dry mouth and 
constipation.30 These drugs may promote more harm than good to many patients, especially 
among older populations. The treatment of older adults with bladder antimuscarinics is also 
being called into question due to a significant association with cognitive decline and an increased 
risk of cardiovascular disease and mortality.63,64,65 Anticholinergics are the most common 
prescribed medication for OAB, but only perform modestly better than placebos.28 
Medicinal therapy is more effective when initiated in conjunction with behavioral 
interventions such as fluid management, avoidance of caffeine and alcohol, bladder retraining, 
and double voiding and should be used as a first line of treatment.30,66 Patients using behavioral 
modifications report equal or superior QoL and are less bothered by their symptoms than patients 
using standard care.30 One study showed that among those using behavioral management 
strategies UI severity decreased by 61% after two years while the control group severity 
increased by 184%.67  
Therapies which focus solely on myogenic dysfunction of the lower urinary tract can 
result in inadequate and unreliable outcomes since OAB symptoms do not indicate one single 
disease. The lack of consistent pathology, symptom presentation, and treatment for a condition 
under a single diagnosis for all patients may promote frustration. Frequency, urgency, urge 
incontinence, and nocturia are caused by numerous pathologies.28 Rather than lumping together a 
group of symptoms, individual symptoms should be investigated separately to understand their 
individual risk factors and underlying pathophysiology. Also, encouraging the opinion that 
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symptoms, however mild, are part of a single medical syndrome risks overmedicalization. 
Approaching OAB examinations and research from different angles will provide insight into the 
multifactorial nature of this chronic condition. The relationships between risk factors, neural 
pathways and bladder outcomes are only just beginning to be understood and will reduce future 
OAB public health burden. Moving toward effective treatment of symptoms through recognizing 
individual patient history and pathologic conditions will require abandoning the antiquated 
concept of an OAB symptom complex or a bladder-centric condition.  
Stratifications to Represent Failure of Linkage of Symptoms to Function  
Numerous studies have examined the experience of OAB on the individual and 
population level, yet the etiology remains complex and not well understood. The suggestion of a 
single clinical entity for OAB symptoms implies that there is a singular etiology and a uniform 
treatment when in fact similar symptoms may present bother as a result of different disease 
processes. UI and OAB, along with other LUTS, are associated with numerous comorbidities, 
suggesting shared etiologies and further complicating the relationship between function and 
symptoms.68 There is also agreement among experts that the pathophysiology of OAB is 
incompletely characterized because of the diversity of experiences across the patient spectrum.40 
Some experts suggest that OAB experiences should be phenotyped, but that does not come 
without its difficulties.69 To further illustrate the failure of the term OAB to represent a singular 
consistent entity and question the focus on the bladder organ, we can examine the experience 
stratified by age (Table 1) as well as compared to similar diagnoses (Table 2).  
(1) Age Stratification  
The age-dependent nature of OAB suggests that bladder dysfunction and related 
comorbidities are determined by aging. In older patients, the condition becomes a geriatric 
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syndrome; having multifactorial etiology and substantially impacting quality of life.25 An 
association of storage, voiding, and incontinence symptoms with conditions increasingly 
common in older adults, including diabetes, hypertension, depression, and constipation, further 
influences clinical presentation and outcomes, compounding the impact of urinary symptoms on 
life quality in older adults.70 Aging is characterized by general degradation in homeostatic 
mechanisms in the body.25 Homeostasis is the maintenance of numerous mechanisms with an 
aggregate effect of sustaining consistency in physiologic conditions regardless of external 
influences. As homeostatic regulation is impaired with aging, the capacity to respond 
appropriately to various challenges is diminished.25 It can be a challenge to determine the 
relative effect of aging in older populations when considering the increasing impact of chronic 
conditions as both may share biological pathways.26 In order to relate symptoms to dysfunction 
in an aging patient, there must be a causal understanding of how aging impacts bladder control. 
The term OAB makes this connection difficult, implying that the dysfunction resulting in the 
symptoms is DO rather than underactive control of the brain mechanisms that maintain 
homeostasis in healthy adults. Evidence from the age-dependent nature and neural control of 
OAB suggests that the current therapeutic model and terminology highlighting detrusor over 
activity overlooks the important function of cognitive control, conscious or unconscious. 
Understanding how physiological mechanisms change with age is critical to the development of 
appropriate diagnoses and treatments, particularly in today’s rapidly aging society. The 
representation of OAB across the spectrum of age in Table 1 reveals the failure of the term OAB 
to represent the varying etiologies and symptom outcomes.  
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Table 1: Stratification of OAB Prevalence, Comorbidity, Bother, and Health Care-Seeking 
by Age  
Age Population 
Prevalence of 
OAB from 
EPIC18 
(extrapolated 
from graphs) 
Population 
Prevalence of 
OAB from 
EpiLUTS6 
Population 
Prevalence of 
OAB from 
NOBLE71 
(extrapolated 
from graphs) 
Population 
Prevalence 
Comorbidities72 
Population Prevalence 
of Bother from 
Urgency  
(extrapolated from 
graphs) 
Prevalence of 
Health Care-
Seeking in OAB 
Population52 
40-44 • 8% men 
• 11% women 
Sometimes 
• 17% men 
• 37% women 
  
Usually 
• 8% men 
• 26% women  
• 12-18% men  
10-22% 
women  
• 18% have 
multiple 
chronic 
conditions 
Men 30-4973 
• Small bother: 17% 
• Moderate bother: 
4% 
• Severe bother: 1% 
 
Women 40-5074 
• Any bother: 28% 
• Moderate-severe: 
10.6% 
 
• 24-33% men  
• 27-36% 
women  
45-64 • 8-15% men 
• 11-16% 
women 
 
Sometimes 
• 21-34% men 
• 41-47% 
women 
  
Usually 
• 10-20% men 
• 29-37% 
women  
• 18-26% men 
• 22-23% 
women 
• 51% have 
multiple 
chronic 
conditions 
Men 50-6973 
• Small bother: 32% 
• Moderate bother: 
9% 
• Severe bother: 3% 
 
Women 50-6074 
• Any bother: 42% 
• Moderate-
severe:15% 
 
• 33-46% men  
• 36-52% 
women  
 
>65 • 16-23% men 
• 15-20% 
women 
Sometimes 
• 34-50% men 
• 45-51% 
women 
  
Usually 
• 20-35% men  
• 36-43% 
women  
• 30-35% men 
• 30-32% 
women 
• 82% have 
multiple 
chronic 
conditions 
Men 70-8973 
• Small bother: 40% 
• Moderate bother: 
14% 
• Severe bother: 6% 
 
Women 60-80+74 
• Any bother: 46-
59% 
• Moderate-
severe:19-31% 
 
• 58-62% men  
• 54-57% 
women  
 
OAB=Overactive bladder, EPIC= European Prospective Investigation into Cancer and Nutrition, 
EpiLUTS= Epidemiology of Lower Urinary Tract Symptoms, NOBLE= The National Overactive Bladder 
Evaluation 
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Table 1 provides a description of studies that examine OAB by age. Most OAB studies 
do not stratify by comparable age groups, use consistent definitions, or research similar 
populations. Therefore, stratification is limited to a small number of studies, but trends can still 
be seen across the existing data. EPIC, EpiLUTS, and NOBLE studies were chosen for 
prevalence stratification by age for their large population size, ICS definition, and relatively 
comparable age groups. These studies show how prevalence increases with age in both genders. 
These aging populations also experience comorbidities that can impact HRQoL and influence the 
OAB disease experience. Related to an increasing severity, health care-seeking also increases 
among those with OAB with age. These stratifications represent a few elements of the OAB 
experience that diversify the diagnosis. Older adults experience a geriatric syndrome, related to 
other chronic conditions, with a potential underlying age-related cause.  
There are also stratifications that aren’t represented in Table 1. While symptom bother 
was reported by 54% of those with OAB, subgroups within the OAB population experience 
symptom severity and bother at widely varying degrees.75 Those with OAB-wet (with UI) 
experience more bother than those with OAB-dry.75 Further, although women are more likely to 
experience UI, significantly more men with UI reported bother than women with UI.75 UI is 
presented differently by age as well, with older groups experiencing more urge urinary 
incontinence (UUI) and younger groups experiencing more stress urinary incontinence (SUI).76 
There are also race and ethnic differences in prevalence and health beliefs related to LUTS and 
OAB that determine burden and healthcare seeking.44 Healthcare seeking is confounded by 
factors such as social influences and connectivity to others with similar symptoms that is 
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associated with both age and symptom severity.77 It is also not rare that studies contradict each 
other in their results.  
(2) Stratification by Condition 
 Just as age stratification demonstrates the lack of a single pathology and undermines the 
use of the term OAB, comparing OAB to another bladder symptom complex, UAB (underactive 
bladder), exposes the potential for a unifying pathology external to the bladder influencing the 
expression of symptoms. The similarities shown in Table 2 between OAB and UAB demonstrate 
how the brain-bladder axis effects bladder dysfunction. While OAB is the more widely 
acknowledged of the two, both have an unknown or inconsistent etiology and arise from an 
impairment of the micturition reflex, whether on the myogenic or neurogenic level. An impaired 
sensory integration and therefore compromised neural control mechanism could account for both 
directions of dysfunctional control (over or under). I hypothesize that overactive bladder is 
associated with underactive neural control of the bladder and suggest the brain might be a better 
witness to the source of urinary dysfunction than the bladder.  
Table 2. Comparison of OAB and UAB 
 OAB Similarities UAB 
Dysfunction • Lack of neural 
inhibition78 
• Detrusor overactivity in 
some cases61 
• May be caused by 
increased efferent 
signals from the brain to 
the bladder78 
• May be caused by 
increased afferent 
signals from the bladder 
to the brain79,80 
 
• Associated with aging30,81 
• Unknown/inconsistent/idiopathic 
etiology30,82 
• Impairment of the micturition reflex78 
o Myogenic 
▪ Age-related bladder 
changes83  
▪ Abnormalities of the 
urothelium, interstitial cells, 
ganglia and smooth muscle 
cells that activate afferent 
nerve fibers84,85 
o Neurogenic 
▪ Nervous system 
dysfunction86,87 
• Detrusor underactivity in 
some cases90 
• May be caused by decreased 
efferent signals from the 
brain to the bladder85,91 
• Can be due to chronic 
obstructive or neurologic 
damage92 
• May be cause by decreased 
sensitivity of the bladder91 
• May be caused by decreased 
afferent signals from the 
bladder to the brain79,, 
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▪ Failure of integration or 
processing in neural circuits78 
• Dysfunction of neural 
bladder control 
mechanisms88 
• Dysfunction of attentional 
switching mechanisms89 
 
Symptoms • Urgency with or without 
urge incontinence, 
usually with increased 
frequency and nocturia5 
• May have overactive 
detrusor61 
• Distinguished by 
urgency5 
• Symptom complexes with shared 
symptoms including frequency, urgency, 
and nocturia and can include 
incontinence 5,82 
• Diminished sense of when the bladder is 
full 
• decreased control over bladder87 
• Both can occur together—detrusor 
hyperreflexia with 
impaired contractility (DHIC) 93 
OAB may progress to UAB87 
• Symptoms and severity of UAB vary 
from one person to another, and the 
course of the disease is often 
unpredictable38, 87 
• A symptom complex 
suggestive of detrusor 
underactivity which is 
usually characterized by 
prolonged urination time 
with or without a sensation 
of incomplete bladder 
emptying, usually with 
hesitancy, reduced sensation 
on filling, and a slow stream 
82 
• Diminished sense of when 
the bladder is full94 
• May have high residual 
urine92 
• May have underactive 
detrusor 90 
• No single distinguishing 
symptom81 
 
Treatment Pelvic floor exercises, 
delayed voiding, 
neuromodulation, anti-
muscarinics30 
Scheduled voiding, bladder diary, dietary 
changes30,92  
 
 Double voiding, catheterization, 
Surgery, muscarinic receptor 
agonists92 
 
Experience  • Abundance of research 
studies30 
• Challenging to diagnose and treat 
o Lack of objective tests and 
biomarkers5,82  
▪ Does not correlate well with 
urodynamics 61,90  
o Lack of consensus on terms 40,95  
o Therapeutic measures are largely 
palliative in nature and associated 
with significant morbidities. 30,92  
o Often remains undetected and 
undertreated 58 
o Mechanisms not well-understood 87 
• Related to stigma, embarrassment, and 
reduced QoL12,96  
• Age dependent 30,92  
• Affects both genders18,96  
• Chronic condition 9, 87 
• Shortage of studies82 
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• Risk factors and common comorbidities: 
MS, spinal cord injury, diabetes, 
Parkinson’s disease, stroke, dementia, 
impaired mobility, UTIs, bladder outlet 
obstruction, smoking and obesity 30,97 
OAB=Overactive Bladder, UAB=Underactive Bladder 
Hypothesis 3: Overactivity of the Bladder and Underactivity of the Brain  
Age-Related Changes in Bladder Tissues 
Shifting away from a bladder-centric view of OAB does not mean the rejection of 
evidence signifying age-related bladder changes. OAB has been associated with observable 
alterations to tissues and responsivity as the bladder ages. These changes, including those in the 
urothelium, neurotransmitters and receptors, and inflammation levels have all been implicated as 
the source of the age-dependent distribution of OAB.84 First, an increase in collagen content 
resulting in urinary fibrosis may be responsible for the decreased bladder compliance seen with 
aging.97 Further, the urothelium is a complex organ that receives and transmits information about 
the bladder.98 It is possible that age-related reductions in neurotransmitters released from bladder 
nerves, including ACh and ATP, might be responsible in part for OAB in aging adults.99 There 
are also changes in muscarinic receptors in the bladder associated with normal aging that might 
impact bladder function.100 Inflammation is a new field of research, and elevated inflammation 
biomarkers in older adults might be related to overactive bladder.84 Innervation of the bladder 
decreases with age in those with OAB, however there is no evidence of declines in detrusor 
smooth muscle contractility or excitability as people age.  101 These alterations in the bladder 
tissues attributable to age might affect how appropriately the bladder responds to normal efferent 
signals or enhance the effect of abnormal signals.  
Normal Bladder Reflex Physiology 
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It is helpful to move away from a bladder-centric model of OAB to fully understand the 
basis for disease. There are impairments to central neural processing that can amplify the age-
related dysfunctions of the bladder and sensory systems. The normal physiology of the brain-
bladder axis is complex and not fully understood, but existing evidence suggests that OAB may 
be a result of underactive control more than overactivity of the bladder. Consistent bladder 
control is a result of neural integration of somatic stimulation, autonomic reflexes and high-level 
control and decision-making mechanisms about when and where to void.78 The normal 
physiology of the bladder is rooted in the neural control of the spinobulbospinal voiding reflex 
responsible for switching the system between storage and voiding.102 The lower urinary tract is 
constantly monitored and modulated by the brain in response to afferent information from 
bladder wall tension.103 As the bladder fills in the storage phase, the brainstem’s periaqueductal 
gray (PAG) receives afferent signals.78  The PAG sends signals to the pontine micturition center 
(PMC) or “Barrington’s Nucleus”, which relaxes the urethral sphincter and causes an involuntary 
void.78 
 Automatic relaxation of the urethral sphincter is speculated to be controlled by three 
high-level circuits that conduct sensory, motor, emotional, and cognitive processing to reserve a 
voiding behavior for a safe, socially acceptable, and convenient time and place.78,104 The 
micturition reflex and control circuits are outlined in Figure 1. The frontal circuit (1) includes the 
regions includes the insula, thalamus, lateral prefrontal cortex (lPFC), and medial prefrontal 
cortex (mPFC) and is the target of most ascending signals from the PAG.78 78  Sensations from 
the bladder are registered in the insula, where the sensory information is put into context.78 With 
the goal of maintaining homeostasis, contextualized information from the insula is then used to 
make the decision to void or to continue storing.105 The midcingulate circuit (2) includes the 
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supplementary motor area (SMA) and dorsal anterior cingulate cortex (dACC) and serves as a 
secondary process in cases of failure by the frontal circuit.78  The ACC determines how to react 
to visceral signals from the bladder depending on the situation.103 The dACC triggers activation 
of the SMA to activate muscles of the pelvic floor and urethreal sphincter.105 The subcortical 
circuit (3) involves the hippocampal and paralimbic regions and serves as a third reinforcement 
against incontinence. This circuit evaluates the safety of the voiding behavior and influences 
voiding decision-making.103 
 
Figure 1. Model of brain-bladder control. PAG= Periaqueductal Grey, dACC= dorsal anterior 
cingulate cortex, lPFC=lateral prefrontal cortex, mPFC=medial prefrontal cortex, ON=Onuf nucleus, Sa= 
sacral cord, SMA= supplementary motor area, th=thalamus. From de Groat WC, Griffiths D, Yoshimura 
N. Neural control of the lower urinary tract. Compr Physiol 2015;5(1):327–96 78 
 
Age-Related Changes in Neural Control 
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Adults without OAB can maintain continence through these inhibitory controls and make 
calm decisions about when to void. The dysfunction of these inhibitions, or the underactivity of 
control is what this paper proposes to influence the cause of OAB symptoms. OAB patients 
exhibit abnormal connections between inhibitory circuits, recruiting accessory circuits involving 
the parieto-temporal lobes, parahippocampal gyrus, and cerebellum.106 Irrespective of the 
bladder, there are differences in motor and sensory regions (precentral and postcentral gyrus) as 
well as attention (inferior parietal) and decision-making regions (inferior and superior frontal 
gyrus) between those with and without OAB.107 
 The overall influence of age on the brain is a general decrease of response in all areas, 
potentially responsible for the reduced sensory feedback required for bladder control.108 Brain 
responses differ in old and young individuals with OAB despite similar symptoms, reiterating the 
earlier point of inconsistent etiology under the same term and exemplifying the potential for 
inhibition interruption in older adults.108 When younger adults experience urgency, there are 
reduced responses at smaller bladder volumes and exaggerated responses at high volumes. In 
older adults, small volumes elicit stronger responses and more modest responses at large 
volumes.108 Also, white matter hyperintensities (WMH) are associated with aging, cognitive 
impairments and incontinence and might be responsible for decreasing neural connectivity 
hindering inhibition circuits.108 
The brain normally has the ability to switch attention to address the most immediate 
concern or threat to safety. Until an alert from the bladder that it is getting full, attention may not 
be focused on the bladder, instead fixing on more pressing matters. There is existing evidence 
that suggests that attention is a crucial element of age-related decline in cognitive control of the 
bladder. In normal physiology, PMC innervates the bladder neurons as well as the locus 
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coeruleus (LC), which in turn activates the cortex increasing arousal to stimuli and shifting 
attention.89 Functional MRI studies have demonstrated that the orbitofrontal cortex, involved in 
cognitive processing and decision making, is increasingly activated in those with normal bladder 
control, but weak among those with OAB regardless of detrusor activity.109 Additionally, 
emotional interference in the limbic system might also be implicated in attentional switching. 
The insula, ACC, and mPFC become less activated and signals in the frontal and midcingulate 
circuits less substantial as people age, reducing the ability to maintain continence regardless of 
OAB diagnosis.110 In subjects with OAB, fMRI studies show there is increased activation in the 
limbic cortex including the ACC and insula associated with urgency suggesting that urgency 
promotes an increased emotional response in those with OAB.109,111 The overwhelming 
emotional conflict of potential social embarrassment due to leakage can impair inhibition 
processes in those with OAB.112 Increased emotional response might reduce the ability to switch 
focus away from the troubling sensation of a filling bladder, promoting urgency.  
Beyond the visceral substantiation, the hypothesis that overactive bladder is primarily 
modulated by underactive cognitive control is exemplified by empirical evidence. Older adults 
have a harder time multitasking, disengaging from distractions, and switching between focuses 
which may be potentially related to the neural integration dysfunctions we see in those with 
OAB.113 Urgency can be influenced by circumstances, and often plays tricks on OAB sufferers, 
determined by the immediacy of finding a bathroom or having limited competing distractions, 
not necessarily signaling a full bladder.12 Those with OAB and incontinence cite common 
triggers such as putting the house key in the door and undoing pants in preparation for using the 
bathroom that often prompt urgency and leakages.37  
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These triggers highlight the influence of inappropriate attentional switching, lack of 
conscious control and indicate the influence of what can be called the “forgetful bladder”. The 
“forgetful bladder” is part of a complex interaction of aging bladder tissues, sensory networks, 
neural integrations and cognitive attentional abilities that may account for a lack or excess of 
attention as a result of bladder filling. The cognitive ability to forget a sensation is evolutionarily 
beneficial to maintain homeostasis and can allocate appropriate attention to the most pressing 
concern, but any imbalance could result in the abnormal storage and voiding symptoms 
categorized as OAB. 
Discussion 
 
This thesis is an attempt to comprehensively summarize the current literature describing 
the condition of OAB and how the sole focus on the bladder is a detriment to public health. OAB 
is defined as a condition with no known underlying condition so attempting to understand a 
potential cause is part of the effort to decrease disease burden. There is neither established 
natural history nor causal understanding of OAB, both of which are vital for effective public 
health prevention and control.114 Recent years have seen the major increase in available therapies 
for OAB, but none are entirely curative. This situation could be because most research has 
focused on the bladder organ as the source of dysfunction. With appropriate causal 
understanding and more accurate diagnoses, more focused treatments may be assigned. 
The proposal to invest research into the cognitive control of the bladder is a result of a 
literature review and the determination of gaps in current knowledge. Piecing together literature 
that approaches OAB from many different angles brought me to the synthesis of my hypothesis 
that the urgency sensation that is a hallmark of OAB may be a product of the brain’s diminished 
ability to administer appropriate attentional focus to physiological changes as a result of aging. 
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These attentional errors related to both aging and OAB may be compounded by age-related 
changes at the bladder level. There may be heightened amount of sensory information being sent 
to the brain encouraging the higher processes to immediately seek a place to void at lower 
volumes or the decreased sensitivity to the sensory information being sent from the bladder 
producing an insufficient reaction to the filling bladder until urgency is the only option (cite 
both). The underactivity of cognitive control of the bladder may also prove to be the dysfunction 
influencing idiopathic OAB, UAB, or other urinary control symptoms.  
The available literature is written from a variety of professional perspectives including 
epidemiological, clinical, and experimental. Examining all of it together highlights the need for 
future research to merge disciplinary silos. Chronic diseases like OAB affect the individual 
across the spectrum of the social-ecological model: genetic and lifestyle risk factors can generate 
numerous dysfunctions that may interact to present a variety of symptoms, interpersonal 
relationships with health care providers may determine treatments, and societal norms may 
influence stigma and care-seeking behaviors. This hypothesis paper attempts to emphasize how 
interprofessional research may reveal OAB dysfunction and an effort was made to include 
research taking diverse approaches. However, this broad goal of understanding all angles may 
also be a limitation, as the review could not be systematically focused around a single element of 
OAB literature.  
Conclusion 
Today’s aging population is continually increasing the number at risk for chronic 
conditions. OAB is a common condition that poses a considerable threat to quality of life, but 
few effective therapeutic measures are available. Advancing age is implicated as the greatest risk 
factor for incidence and severity of OAB, and special attention should be paid to the bladder 
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symptoms of the aging population. This thesis summarizes how OAB is a symptom complex 
with vague terminology representing a variety of co-occurring LUTS. By synthesizing the 
literature, this paper aims to illuminate how the bladder-centric nature of OAB terms is 
misleading. The first hypothesis was that this classification of OAB negatively impacts public 
health. Secondly, this review hypothesized that there is a potential for underlying age-related 
conditions separate from the bladder. Remarking on the failure of linkage from symptoms to 
function, this hypothesis is expressed by stratifying prevalence and experience by age and 
displaying similarities across bladder control conditions. When OAB is compared to UAB, 
sensory integration and control malfunction arises as a commonality between the two conditions, 
accounting for the unique symptoms of each complex. The bladder is part of a complex network 
involving neural control systems that are affected by age. The analysis of existing research leads 
to the third hypothesis that the cognitive and attentional deficits of sensory integration in an 
aging brain directly impact the overactive bladder. Information synthesized in this thesis 
suggests that a more thorough understanding of the attentional mechanisms could encourage new 
management strategies.  
Investment into research on cognition and bladder control would require a paradigm 
switch from a bladder-centric view of OAB to include the possibility for neural integration 
dysfunction. The fact that at least half of urgency and leakage episodes vanish when using 
mindful urge suppression strategies alone is convincing evidence for the power of the brain over 
the bladder and suggests that cognitive circuits are a useful target for OAB therapies.115 Future 
research should describe the relative contributions of motor, sensory, biomechanical, and 
cognitive dysfunctions to bladder function associated with aging. To understand the effect of 
emotional or cognitive function on urgency and bladder dysfunction researchers should combine 
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brain-scanning and urodynamic practices while performing distracting or emotional tasks. If 
cognitive function is found to be substantially linked to urgency in older adults, researchers can 
assume that bladder sensations might be sufficiently distracting to hinder performance of 
previously achievable tasks such as driving.  
Public health professionals can advocate for this perspective change as it might result in 
more helpful diagnosing techniques when patient history suggests age-related cognitive decline, 
thus reducing the population suffering without a cure for OAB. Recognizing the failure of the 
term OAB to represent dysfunction and improve health, and subsequently investigating the role 
of cognition in bladder control could reduce chronic disease burden in the older adult population, 
improving health-years as life-years are continuously extended.  
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